Dalcor Pharma Uk Ltd
09429551
Some Concerns
- Negative net worth (-10)
- 3 outstanding charges (-6)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 14/08/2024
INVESTMENT BANKER
LEBANESE · UNITED ARAB EMIRATES · Age 52
Persons with Significant Control
Former PSCs
Olivier Desmarais
Ceased 04/07/2020
France Chretien Desmarais
Ceased 04/07/2020
Guy Desmarais
Ceased 04/07/2020
Andre Desmarais
Ceased 04/07/2020
Charges3 outstanding
ROCLAD ANSTALT
ROCLAD ANSTALT
ROCLAD ANSTALT
ANDES GROWTH HOLDCO INC
CompanyRankvs 1166+ SIC 72110 peers48
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
-£171.0M
Balance sheet strength
Cash
£338k
Cash in the bank
Net Current Assets
£2.7M
Working capital
Current Assets
£4.6M
Current Liabilities
£1.9M
Fixed Assets
£1.2M
Debtors
£4.3M
Profit After Tax
-£23.7M
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | 2.39 | -£34.1M |
| 2023 | 5.50 | +£16.5M |
| 2022 | 0.04 | -£124.4M |
| 2018 | 1.57 | — |
Derived from filed accounts. Not audited figures.